Stay connected and up-to-date on the latest news and reports. It’s never been easier to know what’s going on in digital health.
2024 has been off to a great start at HealthXL, with topics ranging from Tech Enabled Change in Oncology Workflows to a Masterclass: The Legacy of Pear Therapeutics
Read more%20(2).png)
The surging growth in digital health over the last decade may have slowed, but the potential of digital to transform healthcare remains. Digital health companies alongside pharma, MedTech, and other key stakeholders must come together and form strategic partnerships that play to their strengths.
Read more.png)
The path to achieving digital health compliance in software as a medical device (SaMD) and digital health product development can feel like walking a tightrope. With compliance accounting for about 50% of development spend, the task is significant. What can we do about this?
Read more%20(1).png)
As AI reshapes the landscape of healthcare and life sciences, keeping abreast of emerging trends, breakthrough technologies, and innovative applications has become crucial. To help you stay ahead of the curve, we're thrilled to launch our "AI in Healthcare and Life Sciences Community".
Read more%20-%20Final%20(1).png)
Pride month has come around again. Companies' logos are more colourful, and what were once protests for equal rights have become parades and celebrations in many parts of the world. Yet, LGBTQIA+ communities still face discrimination within many facets of life; especially when accessing healthcare.
Read more%20(2).png)
It's been another month of great events at HealthXL. Our Boston Global Gathering was a roaring success. We also hosted many virtual roundtables and masterclasses on a number of topics. Additionally, we ran a great webinar on what pharma and MedTech can learn from each other in digital health.
Read more%20(1640x920).png)
HealthXL held its second Global Gathering of the year, in collaboration with Takeda, around the theme of Pharma 3.0: The Next Frontier of Digital Health. The event gathered senior leaders from across the pharmaceutical, MedTech and digital health industries, as well as investors and academics.
Read more%20(1).png)
In this week’s blog, guest author Ahmed Albaiti (Principal, ZS), makes a case for why the recent wave of bad news in digital health may just be the focused push that the industry needs.
Read more%20(2).png)
In the recent years, patient engagement has gained great popularity in healthcare. The most impactful and adoptable solutions come from involving patient experts, key opinion leaders and other key stakeholders in a collaborative 'co-creation' process.
Read more.png)
Our HealthXL meetings in April covered everything from ‘Data Monetisation for MedTech Companies’ to ‘The Potential of OTC DTx Solutions’. To make sure you’re not missing out on the top insights from our communities, and get a sneak peak at some of the conversations, here are my top five takeaways.
Read more
ViVE has always been an essential event for digital health decision-makers, offering invaluable insights into the evolving landscape of healthcare.
Read more
2024 has been off to a great start at HealthXL, with topics ranging from How to Scale Partnerships Between Lifesciences and Digital Health Companies? to Real World Data in Clinical Trials: Benefits and Best Practices.
Read more
AI holds the promise of revolutionising clinical trials, specifically by automating and optimising critical processes. The technology has the capability to significantly boost productivity, cut costs, and accelerate the overall timeline of clinical trials.
Read more.png)
Many of you may still be relishing in the holiday bliss, but for HealthXL, the new year is already in full swing. Before we properly close the door on last year, I wanted to take a minute (or so …) to reflect on the tumultuous year that has been.
Read more
As the year draws to a close so does our AI spotlight series. The series catered to many different interests with topics and conversations focused on themes such as Does AI Guarantee ROI and Revolutionising Pharma: AI's Impact on the Value Chain.
Read more
The HealthXL community convened in Princeton, New Jersey. In collaboration with Otsuka, HealthXL organised its fourth Global Gathering of the year around the theme of Leveraging Data-Driven Strategies for Improving Patient Experience.
Read more
By embracing digital measures, pharma can accelerate drug development and improve patient outcomes. Pharma can and will continue to compete on assets, but should not compete on (digital) endpoints. We require industry collaborations in order to usher in a new era of medicine.
Read more
It's been another month of great events at HealthXL, with topics ranging from Enhancing Patient Experiences with Data-Driven Insights to PDT 2.0: The Future of Prescription Digital Therapeutics. To make sure you don't miss the top insights from our community meetings, here are my top five takeaways.
Read more